Connection

SANJEEV VASUDEVAN to Animals

This is a "connection" page, showing publications SANJEEV VASUDEVAN has written about Animals.
Connection Strength

0.365
  1. Dinaciclib improves treatment response in chemoresistant hepatoblastoma. Sci Rep. 2025 Dec 05; 16(1):1410.
    View in: PubMed
    Score: 0.053
  2. A novel treatment strategy utilizing panobinostat for high-risk and treatment-refractory hepatoblastoma. J Hepatol. 2024 04; 80(4):610-621.
    View in: PubMed
    Score: 0.047
  3. HepT1-derived murine models of high-risk hepatoblastoma display vascular invasion, metastasis, and circulating tumor cells. Biol Open. 2022 09 15; 11(9).
    View in: PubMed
    Score: 0.042
  4. Investigating the oncogenic role of aberrant EZH2 in hepatoblastoma. Sci Rep. 2026 Feb 06; 16(1).
    View in: PubMed
    Score: 0.013
  5. MKP-8, a novel MAPK phosphatase that inhibits p38 kinase. Biochem Biophys Res Commun. 2005 May 06; 330(2):511-8.
    View in: PubMed
    Score: 0.013
  6. A humanized mouse model for adeno-associated viral gene therapy. Nat Commun. 2024 03 04; 15(1):1955.
    View in: PubMed
    Score: 0.012
  7. Histopathologic and immunophenotypic characterization of patient-derived pediatric malignant hepatocellular tumor xenografts (PDXs). Pathol Res Pract. 2024 Mar; 255:155163.
    View in: PubMed
    Score: 0.012
  8. CHAF1A Blocks Neuronal Differentiation and Promotes Neuroblastoma Oncogenesis via Metabolic Reprogramming. Adv Sci (Weinh). 2021 10; 8(19):e2005047.
    View in: PubMed
    Score: 0.010
  9. Restoration of the molecular clock is tumor suppressive in neuroblastoma. Nat Commun. 2021 06 28; 12(1):4006.
    View in: PubMed
    Score: 0.010
  10. MDM4 inhibition: a novel therapeutic strategy to reactivate p53 in hepatoblastoma. Sci Rep. 2021 02 03; 11(1):2967.
    View in: PubMed
    Score: 0.009
  11. Small molecule inhibitor agerafenib effectively suppresses neuroblastoma tumor growth in mouse models via inhibiting ERK MAPK signaling. Cancer Lett. 2019 08 10; 457:129-141.
    View in: PubMed
    Score: 0.008
  12. Inhibition of Ubiquitin-Specific Protease 14 Suppresses Cell Proliferation and Synergizes with Chemotherapeutic Agents in Neuroblastoma. Mol Cancer Ther. 2019 06; 18(6):1045-1056.
    View in: PubMed
    Score: 0.008
  13. Cycloheximide sensitivity of orotic acid biosynthesis induced by ammonia and glycine administration. Eur J Biochem. 1998 Feb 01; 251(3):597-604.
    View in: PubMed
    Score: 0.008
  14. A Novel Cell Line Based Orthotopic Xenograft Mouse Model That Recapitulates Human Hepatoblastoma. Sci Rep. 2017 12 19; 7(1):17751.
    View in: PubMed
    Score: 0.008
  15. Indocyanine green fluorescence in second near-infrared (NIR-II) window. PLoS One. 2017; 12(11):e0187563.
    View in: PubMed
    Score: 0.008
  16. p53 Nongenotoxic Activation and mTORC1 Inhibition Lead to Effective Combination for Neuroblastoma Therapy. Clin Cancer Res. 2017 Nov 01; 23(21):6629-6639.
    View in: PubMed
    Score: 0.007
  17. Novel multi-targeted ErbB family inhibitor afatinib blocks EGF-induced signaling and induces apoptosis in neuroblastoma. Oncotarget. 2017 Jan 03; 8(1):1555-1568.
    View in: PubMed
    Score: 0.007
  18. Novel Src/Abl tyrosine kinase inhibitor bosutinib suppresses neuroblastoma growth via inhibiting Src/Abl signaling. Oncotarget. 2017 Jan 03; 8(1):1469-1480.
    View in: PubMed
    Score: 0.007
  19. Wip1 inhibitor GSK2830371 inhibits neuroblastoma growth by inducing Chk2/p53-mediated apoptosis. Sci Rep. 2016 12 19; 6:38011.
    View in: PubMed
    Score: 0.007
  20. Novel patient-derived xenograft and cell line models for therapeutic testing of pediatric liver cancer. J Hepatol. 2016 08; 65(2):325-33.
    View in: PubMed
    Score: 0.007
  21. NSC-87877 inhibits DUSP26 function in neuroblastoma resulting in p53-mediated apoptosis. Cell Death Dis. 2015 Aug 06; 6:e1841.
    View in: PubMed
    Score: 0.006
  22. mTOR ATP-competitive inhibitor INK128 inhibits neuroblastoma growth via blocking mTORC signaling. Apoptosis. 2015 Jan; 20(1):50-62.
    View in: PubMed
    Score: 0.006
  23. Perturbations of endogenous levels of orotic acid and carcinogenesis: effect of an arginine-deficient diet and carbamyl aspartate on hepatocarcinogenesis in the rat and the mouse. Carcinogenesis. 1994 Nov; 15(11):2497-500.
    View in: PubMed
    Score: 0.006
  24. A small-molecule inhibitor of UBE2N induces neuroblastoma cell death via activation of p53 and JNK pathways. Cell Death Dis. 2014 Feb 20; 5:e1079.
    View in: PubMed
    Score: 0.006
  25. Amplification and over-expression of MAP3K3 gene in human breast cancer promotes formation and survival of breast cancer cells. J Pathol. 2014 Jan; 232(1):75-86.
    View in: PubMed
    Score: 0.006
  26. Chronic sensory-motor activity in behaving animals using regenerative multi-electrode interfaces. Annu Int Conf IEEE Eng Med Biol Soc. 2014; 2014:1973-6.
    View in: PubMed
    Score: 0.006
  27. USP7 inhibitor P22077 inhibits neuroblastoma growth via inducing p53-mediated apoptosis. Cell Death Dis. 2013 Oct 17; 4:e867.
    View in: PubMed
    Score: 0.006
  28. TAK1 inhibitor 5Z-7-oxozeaenol sensitizes neuroblastoma to chemotherapy. Apoptosis. 2013 Oct; 18(10):1224-34.
    View in: PubMed
    Score: 0.006
  29. Abnormal hepatic nucleotide pools in sparse fur (spf) mutant mice deficient in ornithine transcarbamylase. Biochem Med Metab Biol. 1992 Jun; 47(3):274-8.
    View in: PubMed
    Score: 0.005
  30. Rapid and transient induction of c-fos, c-myc and c-Ha-ras in rat liver following glycine administration. Biochem Biophys Res Commun. 1988 Apr 15; 152(1):252-6.
    View in: PubMed
    Score: 0.004
  31. Effect of glycine on the induction of orotic aciduria and urinary bladder tumorigenesis in the rat. Toxicol Pathol. 1987; 15(2):194-7.
    View in: PubMed
    Score: 0.004
  32. An earlier proliferative response of hepatocytes in gamma-glutamyl transferase positive foci to partial hepatectomy. Cancer Lett. 1994 Jun 30; 81(2):229-35.
    View in: PubMed
    Score: 0.002
  33. The development of hepatocellular carcinoma in initiated rat liver after a brief exposure to orotic acid coupled with partial hepatectomy. Carcinogenesis. 1993 Dec; 14(12):2527-30.
    View in: PubMed
    Score: 0.001
  34. The effect of long-term feeding of orotic acid on the incidence of foci of enzyme-altered hepatocytes and hepatic nodules in Fischer 344 rats. Carcinogenesis. 1993 Sep; 14(9):1901-5.
    View in: PubMed
    Score: 0.001
  35. Increasing the interval between initiation and the onset of exposure to orotic acid decreases its promoting effect on rat liver carcinogenesis. Carcinogenesis. 1993 Aug; 14(8):1701-4.
    View in: PubMed
    Score: 0.001
  36. Studies on the effect of dietary orotic acid on mouse liver carcinogenesis induced by diethylnitrosamine. Cancer Lett. 1990 Jan; 49(1):67-71.
    View in: PubMed
    Score: 0.001
  37. Dietary and metabolic manipulations of the carcinogenic process: role of nucleotide pool imbalances in carcinogenesis. Toxicol Pathol. 1987; 15(2):190-3.
    View in: PubMed
    Score: 0.001
  38. Complementarity between two rat liver tumor promoters. Toxicol Pathol. 1987; 15(2):198-201.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.